AI model could help clinicians to understand prostate tumor’s aggressiveness

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S.

Grünenthal acquires Valinor Pharma

The acquisition aligns with Grünenthal’s strategy to expand its product portfolio. Credit: fizkes / Shutterstock. Grünenthal has announced the acquisition of US-based Valinor Pharma, along

Read More »